BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3224611)

  • 1. Polychemotherapy and second-look laparotomy in the management of the ovarian cancer.
    Draca P
    Eur J Gynaecol Oncol; 1988; 9(5):410-4. PubMed ID: 3224611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
    Ngan HY; Wong LC; Ma HK
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
    Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
    Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of second-look laparotomy in treatment of epithelial ovarian cancer.
    McCusker MC; Hoffman JS; Curry SL; Koulos JP; Gondos B
    Gynecol Oncol; 1987 Sep; 28(1):83-8. PubMed ID: 3653773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic and therapeutic value of second-look laparotomy in advanced ovarian cancer.
    Bertelsen K; Hansen MK; Pedersen PH; Larsen G; Nyland M; Jacobsen M; Andersen JE
    Br J Obstet Gynaecol; 1988 Dec; 95(12):1231-6. PubMed ID: 3224088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The controversial 'second-look' laparotomy.
    Bokhman YaV ; Vinokurov VL; Gulo EI
    Acta Obstet Gynecol Scand Suppl; 1992; 155():79-83. PubMed ID: 1502895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced ovarian cancer patients with no evidence of disease after platinum-based chemotherapy: retrospective analysis of the role of second-look.
    Cacciari N; Zamagni C; Strocchi E; Pannuti F; Martoni A
    Eur J Gynaecol Oncol; 1999; 20(1):56-60. PubMed ID: 10422684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant chemotherapy of cancer of the ovary].
    Cappelaere P; Horner-Vallet D; Demaille A
    Bull Cancer; 1984; 71(4):363-9. PubMed ID: 6498348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-look laparotomy in the management of patients after radical surgery for ovarian cancer.
    Tuxen MK; Lund B; Hansen OP; Hansen M
    Ann Oncol; 1993 Feb; 4(2):169-71. PubMed ID: 8448085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.
    Hørding U; Toftager-Larsen K; Lund B; Dreisler A; Daugaard S; Lundvall F; Knudsen JB; Bock JE
    Eur J Gynaecol Oncol; 1994; 15(3):217-21. PubMed ID: 7957327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-look laparotomy in ovarian cancer.
    Creasman WT
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S122-7. PubMed ID: 7835795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration.
    Lippman SM; Alberts DS; Slymen DJ; Weiner S; Aristizabal SA; Luditch A; Davis JR; Surwit EA
    Cancer; 1988 Jun; 61(12):2571-7. PubMed ID: 3365677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative second-look laparotomy does not preclude recurrence in stage I ovarian carcinoma of any histological variety.
    Schneider J; Centeno MM; Montoya F; Rodriguez-Escudero FJ
    Eur J Gynaecol Oncol; 1993; 14(1):36-9. PubMed ID: 8472729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of second-look laparotomy in the management of patients with stage II, III and IV ovarian cancers following chemotherapy with cisplatin, adriamycin and cyclophosphamide.
    Kirwan PH; Naftalin NJ; Khanna S; Aukett RJ
    Br J Obstet Gynaecol; 1986 Jun; 93(6):629-33. PubMed ID: 3730331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer].
    Meier W; Römisch M; Hepp H
    Geburtshilfe Frauenheilkd; 1993 Dec; 53(12):860-5. PubMed ID: 8119569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential.
    Barakat RR; Benjamin I; Lewis JL; Saigo PE; Curtin JP; Hoskins WJ
    Gynecol Oncol; 1995 Dec; 59(3):390-3. PubMed ID: 8522261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of second-look laparotomy for ovarian cancer.
    Cain JM; Saigo PE; Pierce VK; Clark DG; Jones WB; Smith DH; Hakes TB; Ochoa M; Lewis JL
    Gynecol Oncol; 1986 Jan; 23(1):14-25. PubMed ID: 3943748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
    Friedman RL; Eisenkop SM; Wang HJ
    Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.